LOGO_COLLATERAL_COLOR_FONDO_BLANCO_237x71LOGO_COLLATERAL_COLOR_FONDO_BLANCO_237x71LOGO_COLLATERAL_COLOR_FONDO_BLANCO_237x71LOGO_COLLATERAL_COLOR_FONDO_BLANCO_237x71
  • Strategies
    • Background
    • Investment Thesis
    • Collateral Good Sustainable Packaging I
    • Collateral Good Sustainable Food Tech I
    • Collateral Good Sustainable Textile & Fashion I
  • Investments
  • About Us
    • Team
    • Advisors
    • Partnerships
    • Newsletter
  • Impact Creation
    • Disclosures
    • Impact Report
  • News
  • Contact
  • Jobs
✕
Back to see more
2

Jarne Elleholm

Partner

Ver perfil de LinkedIn

Jarne has been a Venture Capital Investor as Managing Partner of three Danish-based venture funds with €110 million AUM and 24 portfolio companies as well as held several operational roles at CEO and Vice President levels. Latest he was CEO of Stonehaven Incubate a Swiss-based incubator in the animal health space.
 
He is co-founder, chairman, and angel investor in EvodiaBio, a bio-solutions start-up in the food & beverages space. Jarne has successfully completed an IPO on Nasdaq First North Copenhagen for Aresa and has exited companies such as Action Pharma (acquired by Abbott for $100M), Proxeon (acquired by Thermo Fisher), and Scandinavian MicroBiodevices (acquired by Zoetis for $80M).
 
He is currently Chairman of portfolio company Chromologics ApS, a role he has held for the last 3 years with clear tangible results attained.
 
Jarne holds a university degree in Finance and International Marketing from Copenhagen Business School and has earned an MBA from INSEAD in France.

Privacy

@ Copyright 2024 Collateral Good
All Rights Reserved.